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Abstract
Introduction: A semi-upright position in ventilated patients is recommended to prevent ventilator-associated
pneumonia (VAP) and is one of the components in the Ventilator Bundle of the Institute for Health Care
Improvement. This recommendation, however, is not an evidence-based one.
Methods: A systematic review on the benefits and disadvantages of semi-upright position in ventilated patients
was done according to PRISMA guidelines. Then a European expert panel developed a recommendation based on
the results of the systematic review and considerations beyond the scientific evidence in a three-round electronic
Delphi procedure.
Results: Three trials (337 patients) were included in the review. The results showed that it was uncertain whether a
45° bed head elevation was effective or harmful with regard to the occurrence of clinically suspected VAP,
microbiologically confirmed VAP, decubitus and mortality, and that it was unknown whether 45° elevation for
24 hours a day increased the risk for thromboembolism or hemodynamic instability. A group of 22 experts
recommended elevating the head of the bed of mechanically ventilated patients to a 20 to 45° position and
preferably to a ≥30° position as long as it does not pose risks or conflicts with other nursing tasks, medical
interventions or patients’ wishes.
Conclusions: Although the review failed to prove clinical benefits of bed head elevation, experts prefer this
position in ventilated patients. They made clear that the position of a ventilated patient in bed depended on many
determinants. Therefore, given the scientific uncertainty about the benefits and harms of a semi-upright position,
this position could only be recommended as the preferred position with the necessary restrictions.
Introduction
Ventilator-associated pneumonia (VAP) is defined as
pneumonia in a patient on mechanical ventilatory sup-
port (by endotracheal tube or tracheostomy) for more
than 48 hours. VAP is associated with increased mortal-
ity and morbidity in critically ill patients [1].
Aspiration of oropharyngeal secretions and gastric
contents containing bacteria is considered an essential
step in the pathogenesis of VAP. About 20 years ago,
studies using radiolabeled enteral feeding have shown
more aspiration of gastric contents in supine patients
than in patients in a 45° position [2-4]. None of these
studies assessed the effect of a semi-upright position on
VAP. An observational study demonstrated that a
supine position during the first 24 hours of mechanical
ventilation is an independent risk factor for VAP [5]. In
contrast to these older studies, a nonexperimental study
in 2005 found that only the combination of early, low
backrest elevation <30° and severity of illness affected
the incidence of VAP [6]. A prospective randomized
animal study showed that a semi-upright position
reversed the mucus flow in intubated sheep [7].
As a result of the older studies and the paper published
by Drakulovic and colleagues in 1999 [8], a semi-upright
position for ventilated patients has been promoted to
prevent VAP. Besides its benefits, however, a semi-
upright position may have disadvantages such as venous
stasis in the lower extremities with the risk of venous
thromboembolism [9], caudal shift of blood with the risk
of hemodynamic instability [10], and the risk of bed sores
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in the ‘real life’ of today’s ICUs is debated [11].
The Canadian Critical Care Trials Group, the American
Thoracic Society and Infectious Diseases Society of Amer-
ica, and the Centers for Disease Control and Prevention
recommend the use of a semi-upright position (30 to 45°),
especially in patients receiving enteral feeding [12-14].
Because these recommendations are not based on the
findings of a systematic review, a Dutch-German review
group decided to summarize the evidence of the benefits
and disadvantages of semi-upright positioning in venti-
lated patients by a systematic review of the literature.
Systematic reviews are the basis of evidence-based
recommendations. Next to the scientific evidence, other
considerations play a role in formulating recommenda-
tions for clinical practice. In the second part of this study,
a European expert panel of intensive care specialists devel-
oped a recommendation on bed head elevation based on
the results of the systematic review and considerations
beyond the scientific evidence in a three-round electronic
Delphi procedure.
Materials and methods
Systematic review
Question
Two issues were addressed: should bed head elevation be
higher than standard practice, and which degree of bed
head elevation does more good than harm? Bed head ele-
vation was defined as the angle of the head of the bed and
was expressed in degrees of elevation above horizontal.
Outcomes
Primary outcomes were clinically suspected VAP and
microbiologically confirmed VAP. Clinically suspected
VAP was defined as new or persistent or progressive
radiographic infiltrate with at least two of the following
criteria: fever; leucopenia or leucocytosis; and purulent tra-
cheal secretions. VAP was microbiologically confirmed
when cultures of airway secretions were positive.
Secondary outcomes included mortality, venous
thromboembolism, hemodynamic instability, duration of
mechanical ventilation, length of ICU stay, decubitus
ulcers, patient comfort and patient safety.
Searching
Publications were retrieved by searching Medline and the
Cochrane Library up to 31 January 2010. Search terms
included randomized controlled trial (RCT), backrest ele-
vation and semirecumbent. The complete search strategy
can be found in the electronic supplementary material
(Additional file 1). In addition, the lists of references for
all identified trials were checked for more trials.
Selection
We included studies that were planned as a randomized
trial or a quasi-randomized trial and were also published
as a full paper. The studies had to state the outcome
definitions used and had to present sufficient data to be
able to calculate the risks in both the treatment group
and the control group. No language restrictions were
applied. Two reviewers (BSN-W and AK) assessed all
titles and abstracts independently to confirm the eligibil-
ity of the selected trials. Disagreements were resolved by
consensus.
Assessment of trial quality
Six reviewers assessed trial quality independently by eval-
uating each study to determine concealment of treatment
allocation, double-blinding, completeness of follow-up,
use of intention-to-treat analysis, selective reporting of
events and premature discontinuation of the trial due to
benefit. Central randomization, sealed envelopes or a
similar method was assumed to yield adequate randomi-
zation. The description of dropouts was considered ade-
quate if the number of patients lost and the reasons why
patients were lost to follow-up were reported according
to treatment allocation. Disagreements were resolved by
consensus.
Data extraction, analysis and quality of evidence
The systematic review was performed according to
PRISMA guidelines [15]. Data on the study population,
interventions and outcomes were independently extracted
and cross-checked by six reviewers. Only trial data related
to the question posed in the review were considered.
For the dichotomous outcomes we calculated the overall
relative risk (RR) with a 95% confidence interval (CI) by
means of Review Manager (Version 5; Cochrane Colla-
boration, Oxford, UK), using the standard random-effects
method of DerSimonian and Laird [16]. When appropri-
ate, meta-analyses were undertaken using a random-effects
model to calculate pooled estimates and their 95% CIs.
Subgroup meta-analyses were planned according to feed-
ing via gastric tubes or not; continuous subglottic suction-
ing of oropharyngeal secretions via modified tubes or not;
use of selective digestive tract decontamination or not; use
of antacids or not; and presence of hiatal hernia or not.
B a s e l i n er i s k sw e r ed e f i n e da st h er i s kf o rac e r t a i no u t -
come in the control arm of the individual trials - that is,
the risk for a certain outcome without treatment (total
number of patients with a certain outcome in the control
group/total number of patients in the control group). Pub-
lication bias was examined by visual inspection of a funnel
plot. The quality of the available evidence for each out-
come was assessed by the GRADE method [17].
Development of a recommendation by an electronic
Delphi consensus process
Participants
European experts in intensive care medicine who pub-
lished an article in the field of the prevention of VAP,
who were a member of a national or international plat-
form/research group on VAP prevention, or who were
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for study participation. Furthermore, the study was
announced on the website of the European Society of
Intensive Care Medicine [18] and in the society’s News-
letter, offering every member of the society the opportu-
nity to participate.
Procedure
Three Delphi rounds were performed by a web-based elec-
tronic form in an anonymous fashion. Each round lasted
about 3 weeks. After each round the participants received
a feedback report from the previous round. Nonrespon-
ders were excluded from the next Delphi round.
The first expert consultation was designed to give them
the opportunity to comment on the results of the systema-
tic review, to identify considerations beyond the scientific
evidence of importance for the formulation of the recom-
mendation, and to check first opinions about the phrasing
of a recommendation. A number of possible considera-
tions were proposed by the authors - that is, feasibility of a
semi-upright position, external validity of the scientific evi-
dence, difficulty in measuring adherence to a semi-upright
position, costs, and the use of a semi-upright position in
bundles for the prevention of VAP. These considerations
were presented to the participants, who were asked to
indicate whether they agreed or disagreed by marking one
of the listed answers; to comment their answers in com-
ment boxes; and to add more considerations. Differently
phrased recommendations were presented to indicate
agreement or disagreement as described above. The
experts could formulate their own recommendation if
their preferred recommendation was not phrased.
The second expert consultation depended completely
on the results of the first Internet consultation.
Based on the results of the systematic review and the
results of the first and second rounds, the investigators
proposed a recommendation and motivation for this
recommendation (rationale). In the third Internet round,
the participants were asked to state whether they agreed
or disagreed with the proposed recommendation and its
rationale.
Results
Systematic review
Selection
Two hundred and eight potentially relevant studies were
initially identified by our search. Three studies fulfilled the
selection criteria and were included in the review
[8,19,20]. The flow diagram showing the steps we followed
to identify the RCTs fulfilling the inclusion criteria of our
systematic review can be found in Additional file 1.
Quality assessment of trials
All three trials clearly concealed patient allocation, ade-
quately described dropouts and did not report events in
a selective way. A single trial blinded the investigators
responsible for VAP diagnosi s[ 2 0 ]a n du s e di n t e n t i o n -
to-treat analysis [20]. In one trial, 46% of the rando-
mized patients did not complete the trial [19]. One trial
stopped before the intended sample size was reached
because of benefit [8].
Data extraction, analysis and body of evidence
Data on study populations, interventions and outcome
definitions are shown in Table 1. Three RCTs compared
45° bed head elevation (treatment group) with respectively
25° [19], 10° [20], or 0° [8] elevations (control groups) in
adult ventilated ICU patients with a mean ventilation time
varying from 4 days [19] to 7 days [8]. Patients with hemo-
dynamic instability, pelvis trauma, (recent) abdominal sur-
gery or neurosurgery, and severe obesity were excluded.
All trials addressed clinically suspected VAP. The base-
line risks for clinically suspected VAP across trials ranged
from 15% [19] to 34% [8]. The pooled RR derived from
all trials (337 patients) showed a benefit in favor of the
45° bed head elevation, but with wide confidence inter-
vals (RR = 0.47, 95% CI = 0.19 to 1.17) (Figure 1).
Three trials reported data on microbiologically con-
firmed VAP. One trial included only cultures of bronch-
oalveolar lavages [20], whereas two trials also included
cultures of tracheal aspirates [8,19]. The pooled RR (337
patients) was in favor of the 45° bed head elevation, but
with wide confidence intervals (RR = 0.67, 95% CI =
0.23 to 2.01) (Figure 2).
Three trials reported data on mortality, including 337
patients. The pooled relative risk was in favor of the 45°
b e dh e a de l e v a t i o n ,b u tw i t hwide confidence intervals
(RR = 0.90, 95% CI = 0.64 to 1.27) (Figure 3).
A single good-quality trial reported fewer decubitus
ulcers in the 45° elevation group, but with wide confidence
intervals (RR = 0.91, 95% CI = 0.60 to 1.38) (Figure 4).
None of the trials reported data on venous throm-
boembolism, hemodynamic instability, duration of
mechanical ventilation, length of ICU stay, patients’
comfort and patients’ safety.
The estimated effects on mortality, clinically suspected
VAP and microbiologically confirmed VAP were very
uncertain, because the 95% CIs around the pooled
effects included no effect, appreciable benefit and appre-
ciable harm. Two RCTs exhibited serious limitations in
study quality and execution: Keeley in 2007 had a nearly
50% dropout rate [19], and Drakulovic and colleagues in
1999 stopped prematurely after interim analysis showed
a very large treatment effect in favor of the 45° elevation
[8]. Both of these trials did not use intention-to-treat
analysis and did not specify whether pneumonia asses-
sors were blinded to treatment allocation. There was
uncertainty about the directness of the evidence,
because the standard care for mechanically ventilated
patients with enteral feeding is not a complete horizon-
tal position as it was in one trial [8]. Furthermore, for
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Study Study participants
(number of patients
randomized)
Treatment (T) and
Control (C) groups
(number of patients
analyzed)
Duration
of ICU
ventilation
Outcomes Baseline risks,
%
End of study
protocol
Drakulovic and
colleagues [8]
Respiratory and
medical ICU patients
(90). Excluded:
previous endotracheal
intubation (<30 days);
recent abdominal
surgery; recent
neurosurgical
intervention;
hemodynamic
instability
T (39), 45°; C (47), 0°.
Correctness of the
position was checked
once a day
Mean: T,
145 hours
(SD 149); C,
171 hours
(SD 167)
Clinically suspected
VAP, defined as new
and persistent infiltrate
on chest radiography
and at least two of the
following three criteria:
fever; leucopenia or
leucocytosis; purulent
tracheal secretions: T,
3/39; C, 16/47
Clinically
suspected VAP:
34%
End of study
protocol: (1) first
weaning trial, (2)
extubation, (3) death,
(4) permanent
change in body
position for more
than 45 minutes
Microbiologically
confirmed VAP,
defined as clinical
suspicion and positive
ETS, BAL or PSB: T, 2/
39; C, 11/47
Microbiologically
confirmed VAP:
23%
Follow-up for an
additional 72 hours
after the study end
point has been
reached
ICU mortality: T, 7/39;
C, 13/47
For ICU mortality:
28%
Keeley [19] Adult ventilated
patients with no
contraindications for
raised head of bed
(56). Excluded:
previous endotracheal
intubation (<30 days);
recent abdominal
surgery with vacuum
dressing; severe
obesitas;
hemodynamic
instability; renal
replacement therapy;
pregnancy; spinal
surgery or trauma
T (17), 45°; C (13), 25°.
Authors did not report
whether correctness of
the position was
checked during the
study
Mean
a:T ,
3.8 days; C,
5.1 days
Clinically suspected
VAP, defined as new
and persistent infiltrate
on chest radiography
and at least two of the
following three criteria:
fever; leucopenia or
leucocytosis; purulent
tracheal secretions: T,
1/17; C, 2/13
Clinically
suspected VAP:
15%
End of study
protocol: (1) first
successful weaning
trial, (2) extubation,
(3) death
Microbiologically
confirmed VAP,
defined as clinical
suspicion and positive
ETS, BAL or PSB: T, 4/
17; C, 5/13
Microbiologically
confirmed VAP:
38%
Follow-up for an
additional 72 hours
after the study end
point has been
reached
In-hospital mortality: T,
5/17; C, 4/13
In-hospital
mortality: 31%
van
Nieuwenhoven
and colleagues
[20]
Adult ventilated
patients with no
contraindications for
raised head of bed
and an expected
duration of ventilation
>48 hours (221).
Excluded: selective
decontamination of
the digestive tract;
trauma of the pelvic
region; extensive
abdominal surgery;
neurosurgical patients
treated with 30° head
elevation; patients
cared for in beds
without the possibility
of altering backrest
elevation
T (112), 45°; C (109),
10°. Backrest elevation
was measured every
60 seconds by means
of a transducer with
pendulum. A
dedicated nurse
controlled patient
position two or three
times daily and
restored backrest
elevation to the
randomized position
when possible
Median: T,
6( 0t o
281) days;
C ,6( 0t o
64) days
Clinically suspected
VAP, defined as new
or persistent or
progressive
radiographic infiltrate
with at least two of
the following criteria:
temperature >38°C or
<35°C; leucopenia or
leucocytosis; positive
cultures of tracheal
aspirate: T, 16/112; C,
20/109
Clinically
suspected VAP:
18%
End of study
protocol: (1)
extubation, (2) death,
(3) patients were
placed in a bed
without the
possibility to alter
backrest elevation, (4)
VAP
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analysis revealed marked statistical heterogeneity that
could be explained by flaws in the study design (P <
0.05, τ
2 = 0.61, I
2 = 65.9%) (Figure 2). The two poor-
quality studies indicated a decreased rate of microbiolo-
gically confirmed VAP in the advantage of the 45° eleva-
tion [8,19], whereas the high-quality study indicated an
increased rate of microbiologically confirmed VAP in
t h ed i s a d v a n t a g eo ft h e4 5 °e l e v a t i o n[ 2 0 ] ,b u ta l lw i t h
wide 95% CIs (data not shown).
The estimated effect on decubitus was uncertain
because of imprecision.
The small number of retrieved studies did not allow
any subgroup meta-analysis or any assessment of publi-
cation bias.
No trials were found addressing the issue of which
degree of bed head elevation does more good than
harm.
Development of recommendation by Delphi consensus
process
Participants
Thirty-one intensive care specialists from 12 European
countries were interested in participation. Twenty-seven
of the 31 participants responded in the first Delphi
round (87%). Twenty-four of the 27 invited experts
responded in the second round (88%). Twenty-two of
the 24 invited experts responded in the third round
(91%). Twenty-two experts from 11 European countries
thus participated in all rounds.
Table 1 Study populations, interventions and definition of VAP (Continued)
Microbiologically
confirmed pneumonia,
defined as clinical
suspicion and positive
BAL or positive blood
culture with the same
microorganisms as in
tracheal aspirate: T,
13/11; C, 8/109
Microbiologically
confirmed VAP:
7%
Authors did not
report whether there
was a follow-up for
an additional 72
hours after the study
end point has been
reached
ICU mortality: T,
33/112; C, 33/109
ICU mortality:
30%
Pressure sore
b:T ,
31/112
c; C, 33/109
c
Feasibility of the
allocated position
d
BAL, bronchoalveolar lavage; ETS, tracheobronchial aspirate; PSB, protected specimen brush; VAP, ventilator-associated pneumonia.
aStandard deviation (SD)
could not be calculated; authors did not supply additional information.
bPressure sore was staged daily to the four stages described by the National Ulcer
Advisory Panel System [23].
cMost patients had stage 1 or stage 2 pressure sores.
dThe targeted 45° head of bed elevation was not reached.
Figure 1 Summary estimates of associations between treatment and control groups: clinically suspected ventilator-associated
pneumonia.
1GRADE Working Group grades of evidence: high quality, further research is very unlikely to change confidence in the estimate of
effect; moderate quality, further research is likely to have an important impact on confidence in the estimate of effect and may change the
estimate; low quality, further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change
the estimate; very low quality, the estimate effect is very uncertain. CI, confidence interval; M-H, Mantel Haenszel test; VAP, ventilator-associated
pneumonia.
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Three Delphi rounds were held. The interim results of
the first and second rounds can be found in Additional
file 1. Based on the scientific evidence and the results of
the first and second Delphi rounds, the investigators for-
mulated a recommendation with its rationale (Table 2).
Nineteen experts (86%) agreed on the recommendation
with its rationale.
Discussion
A group of 22 experts in intensive care medicine from
11 European countries recommends elevating the head
of the bed for mechanically ventilated patients to a 20
to 45° position and preferably to a ≥30° position as long
as it does not pose risks or conflicts with other nursing
tasks, medical interventions or patients’ wishes. This
recommendation was based on the results of a systema-
tic review conducted by a Dutch-German review group
and the considerations brought up by the European
expert panel.
Three of the 22 experts disagreed with the recommen-
dation and its rationale. One expert was of the opinion
that no recommendation should be given because of the
low quality of evidence and the lack of data on potential
adverse effects and feasibility. The other two experts
had some additional comments on the rationale that
Figure 3 Summary estimates of associations between treatment and control group: ICU mortality.
1GRADE Working Group grades of
evidence: high quality, further research is very unlikely to change confidence in the estimate of effect; moderate quality, further research is likely
to have an important impact on confidence in the estimate of effect and may change the estimate; low quality, further research is very likely to
have an important impact on confidence in the estimate of effect and is likely to change the estimate; very low quality, the estimate effect is
very uncertain. CI, confidence interval; M-H, Mantel Haenszel test.
Figure 2 Summary estimates of associations between treatment and control group: microbiologically confirmed ventilator-associated
pneumonia.
1GRADE Working Group grades of evidence: high quality, further research is very unlikely to change confidence in the estimate of
effect; moderate quality, further research is likely to have an important impact on confidence in the estimate of effect and may change the
estimate; low quality, further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change
the estimate; very low quality, the estimate effect is very uncertain. CI, confidence interval; M-H, Mantel Haenszel test; VAP, ventilator-associated
pneumonia.
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recommendation.
The systematic review show e dt h a ti ti su n c e r t a i n
whether a 45° bed head elevation is effective or harmful
with regard to the occurrence of clinically suspected
VAP, microbiologically confirmed VAP, decubitus and
mortality, and that it is unknown whether a 45° bed head
elevation for 24 hours a day causes thromboembolism or
hemodynamic instability. In the trial by van Nieuwenho-
ven and colleagues, the target elevation of 45° could not
be reached [20]. Grap and colleagues in 2005 also found
that the mean backrest elevation was consistently lower
than the recommended 30 to 45° [21]. They found an
average backrest elevation of merely 21.7° in ventilated
patients [6,21]. Because the desirable position for venti-
lated patients depends on nursing tasks, medical
Table 2 Recommendation on bed head elevation with its rationale
Considering that (RATIONALE):
1. based on the results of the systematic review,
￿ it is uncertain whether a 45° bed head elevation is effective or harmful with regard to the occurrence of clinically suspected VAP,
microbiologically confirmed VAP, decubitus and mortality;
￿ it is unknown whether a 45° bed head elevation for 24 hours a day causes thromboembolism or hemodynamic instability;
2. maintaining a semi-upright position for 24 hours a day may cause conflict with other nursing tasks or medical interventions like insertion of
intravascular catheters, providing good hygiene to the patient, prevention of decubitus, intensive physiotherapy or wound care, so that semi-upright
position must be abandoned;
3. there are absolute contraindications to nursing mechanically ventilated patients in a semi-upright position - that is, patients with recent thoracic
or lumbar surgery of the spine and patients with thoracic or lumbar spine injury;
4. there are a relative large number of mechanically ventilated patients with relative contraindications where caution is indicated when the patienti s
placed in a semi-upright position - that is, patients with hemodynamic instability; trauma of the pelvic region; and severe sacral decubitus;
5. besides the possible prevention of VAP,
a) semi-upright position of ventilated patients,
￿ might improve oxygenation and ventilation;
￿ decreases facial edema;
b) semi-upright position of awake ventilated patients,
￿ might promote easier communication between patients and relatives or staff, better orientation in the room and more effective coughing;
6.
￿ semi-uptight position of ventilated patients interferes with the prevention of decubitus - that is, changing position frequently;
￿ patients glide away to the foot end of the bed when using anti-decubitus mattresses;
7. the wish of awake patients to change body position regularly should be respected.
8. the intervention is no cost;
European experts in intensive medicine CONCLUDE that the recommendation should not be compelling, because the prevention of VAP is
uncertain and the balance between benefits and harms is unknown, and maintaining semi-upright position interferes with other nursing tasks or
with medical interventions.
The experts RECOMMEND to elevate the head of the bed of mechanically ventilated patients to a 20 to 45° position and preferably in a ≥30°
position as long as it is does not pose risks and conflicts with other nursing tasks, medical interventions or with patients’ wishes.
VAP: ventilator-associated pneumonia.
Figure 4 Summary estimates of associations between treatment and control group: pressure sores.
1GRADE Working Group grades of
evidence: high quality, further research is very unlikely to change confidence in the estimate of effect; moderate quality, further research is likely
to have an important impact on confidence in the estimate of effect and may change the estimate; low quality, further research is very likely to
have an important impact on confidence in the estimate of effect and is likely to change the estimate; very low quality, the estimate effect is
very uncertain. CI, confidence interval; M-H, Mantel Haenszel test.
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elevation for 24 hours a day is not feasible. The RCTs
and the inclusion of bed head elevation in the ventilator
bundle suggest to the relative outsider that a horizontal
position is the standard in ventilated patients and that
changing the position to a semi-upright position requires
great changes in intensive care. The consultation with
experienced physicians in intensive care medicine learned
that some bed head elevation is common for most
patients, suggesting that the trials used artificial controls.
No trial will be able to replicate exact clinical practice
and vice versa.F u r t h e r m o r e ,m o d e r nI C U sa r es oc o m -
plex that investigating bed head elevations in all venti-
lated patients or extrapolating the results to all ventilated
patients is not possible. Perhaps researchers should not
want to investigate bed head elevation policies at all. In
any case, future research should be limited to specific
ICU subgroups.
In 2009 a meta-analysis was published on the impact of
patient position on the incidence of VAP [22]. This meta-
analysis found that a 45° position significantly lowers the
incidence of clinically diagnosed VAP compared with
supine patients. Their conclusion is different from our
conclusion. The main reasons are that in the previous
meta-analysis the benefits and harms of a 45° position
were not addressed; the overall quality of evidence by con-
sidering the items study quality and execution, inconsis-
tency, indirectness, imprecision and publication bias were
not assessed; and in their calculations of clinically diag-
nosed VAP, the authors pooled the data for clinically sus-
pected VAP [8,20] with those for overall VAP [19]. We
recalculated the overall incidence of VAP (clinically sus-
pected VAP plus microbiologically confirmed VAP) using
a random-effects model and did not find a significantly
lower incidence of clinically diagnosed VAP.
The Ventilator Bundle of the Institute for Health Care
Improvement is a series of five interventions related to
ventilator care that, when implemented together, will
achieve significantly better outcomes than each single
intervention. Bed head elevation is one of the above com-
ponents. Only patients with all five elements of the venti-
lator bundle in place are recorded as complying with the
ventilator bundle. We would expect that bundles contain
only interventions that could always be executed and that
were strongly recommended. The European expert group
found that the evidence was too weak, however, and that
there were too many disadvantages of semi-upright posi-
tioning to formulate a strong recommendation. As such,
we question whether compliance with the VAP bundle
should depend on the adherence to this single item.
It is conceivable that the selected participants were not
representative for all experts in intensive care medicine,
but the question is whether this is desirable. In our opi-
nion the selected participants had to be representative for
the mean expert in VAP prevention. We do not see argu-
ments that this would not be the case.
It is important to have a large expert group when
going from evidence to recommendation, because the
spread of answers to some questions was very diverse.
Our expert group could have been a bit smaller, because
we received too many of the same types of answers.
Conclusions
Experts have made clear that the position of a ventilated
patient in bed depends on many determinants. Given the
scientific uncertainty about the benefits and harms of a
semi-upright position, this position can therefore only be
recommended as the preferred position with the necessary
restrictions. The approach we have taken to develop this
recommendation explicits both the scientific evidence and
the arguments beyond this evidence that underpin the
recommendation. The method is well applicable to
develop recommendations that can count on broad sup-
port over the borders of countries and continents.
Key messages
￿ The systematic review showed that it is uncertain
whether a 45° bed head elevation is effective or
harmful with regard to the occurrence of clinically
suspected VAP, microbiologically confirmed VAP,
d e c u b i t u sa n dm o r t a l i t y ,a n dt h a ti ti su n k n o w n
whether a 45° bed head elevation for 24 hours a day
causes thromboembolism or hemodynamic
instability.
￿ Maintaining a certain elevation 24 hours a day is
not feasible, because the desirable position of venti-
lated patients depends on nursing tasks, medical
interventions and patients’ wishes.
￿ The trials investigating b e dh e a de l e v a t i o nu s e d
artificial controls.
￿ A semi-upright position can only be recommended
as the preferred position with the necessary restric-
tions. Whether compliance with the VAP bundle
should depend on adherence to this single item is
therefore questioned.
Additional material
Additional file 1: Bed head elevation study additional information.
File containing the complete search strategy, the flow diagram of
reviewed articles, and more detailed information on the results of the
first and second Delphi rounds.
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